Noticias de ESPR_US

Noticias del mercado

Últimas noticias sobre ESPR_US — 205 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ESPR_US ✕ 205 resultados
31/03/2026 ESPR_US — MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) Trading Up 9.7% - Here's What Happened
30/03/2026 ESPR_US — GlobeNewswire
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026
30/03/2026 ESPR_US — Yahoo Finance
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026
30/03/2026 ESPR_US — GlobeNewswire
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026
26/03/2026 ESPR_US — Stock Titan
Vanguard (ESPR) Amendment: Reports zero ESPR common shares after internal realignment
22/03/2026 ESPR_US — MSN ES ← EN
Esperion (ESPR) destaca la inclusión del ácido bempedoico en las directrices sobre dislipidemia ACC/AHA de 2026
20/03/2026 ESPR_US — Yahoo Finance
Esperion (ESPR) Highlights Inclusion of Bempedoic Acid in 2026 ACC/AHA Dyslipidemia Guidelines
20/03/2026 ESPR_US — Insider Monkey
Esperion (ESPR) Highlights Inclusion of Bempedoic Acid in 2026 ACC/AHA Dyslipidemia Guidelines
18/03/2026 ESPR_US — MSN
Esperion to acquire Corstasis for $75M upfront payment
18/03/2026 ESPR_US — Stock Titan
Esperion Therapeutics (ESPR) CEO sells shares to pay RSU taxes
18/03/2026 ESPR_US — Stock Titan
Esperion (NASDAQ: ESPR) CLO sells 5,708 shares to cover RSU tax bill
18/03/2026 ESPR_US — Investing.com
Esperion Therapeutics CFO Halladay sells $17k in stock
17/03/2026 ESPR_US — Stock Titan
Bempedoic acid data spotlight statin-intolerant, autoimmune patients
17/03/2026 ESPR_US — Stock Titan
ESPR (NASDAQ: ESPR) affiliate files to sell 6,424 vested shares after vesting
17/03/2026 ESPR_US — GlobeNewswire
Esperion to Present Two New Analyses from CLEAR Outcomes
16/03/2026 ESPR_US — Stock Titan
[Form 4] Esperion Therapeutics, Inc. Insider Trading Activity
16/03/2026 ESPR_US — Yahoo Finance
Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia
16/03/2026 ESPR_US — Stock Titan
Esperion (ESPR) CLO receives new stock and option grants
16/03/2026 ESPR_US — Stock Titan
2026 cholesterol guideline backs bempedoic acid for statin-intolerant patients
16/03/2026 ESPR_US — GlobeNewswire
Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia

Página 8 de 11

keyboard_arrow_up